CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026
Go back to CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026| CytoDyn, Inc. (AMEX: CYDY) | Delayed: 0.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.26 | 52 Week High | $1.57 | |||
| Open | $0.26 | 52 Week Low | $0.61 | |||
| Day High | $0.26 | P/E | N/A | |||
| Day Low | $0.26 | EPS | $0.00 | |||
| Volume | 1,658,418 | |||||
